PAHC 23.39 (-1.52%)
US71742Q1067Drug ManufacturersDrug Manufacturers - Specialty & Generic

Phibro Animal Health (PAHC) Competitor Comparison

We are evaluating the key criteria listed to compare Phibro Animal Health (PAHC) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 5 years - PAHC ranking 6 / 54

These are the competitors of Phibro Animal Health in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 5 years
1. Kamada KMDA
233.58
2. Green Thumb Industries R9U2.F
64.25
3. ProPhase Labs PRPH
32.25
4. ANI Pharmaceuticals ANIP
30.53
5. Catalent CTLT
20.23
6. Phibro Animal Health PAHC
17.71
7. Regencell Bioscience Holdings RGC
16.42
8. Evolus EOLS
10.87
9. Neoleukin Therapeutics NLTX
8.58
10. Alvotech ALVO
8.16
11. Alimera Sciences ALIM
7.82
12. Vifor Pharma G2AB.F
7.23
13. PetIQ PETQ
6.43
14. Organogenesis Holdings ORGO
5.29
15. Zoetis ZTS
5.29
16. Linc LNC
4.98
17. Kolinpharma KIP.MI
4.88
18. Perrigo PRGO
4.63
19. Elanco Animal Health ELAN
4.5
20. Pacira BioSciences PCRX
4.39
21. Curaleaf Holdings CURLF
4.33
22. Ironwood Pharmaceuticals IRWD
3.82
23. Ayr Wellness 3KJB.F
3.71
24. Taro Pharmaceutical Industries TARO
3.55
25. Collegium Pharmaceutical COLL
3.31
26. Cronos Group CRON
2.89
27. Journey Medical DERM
2.86
28. Emergent BioSolutions EBS
2.81
29. Bausch Health Companies BHC
2.68
30. Embecta EMBC
2.67
31. Supernus Pharmaceuticals SUPN
2.66
32. Relmada Therapeutics RLMD
2.63
33. Procaps Group PROC
2.59
34. Cumberland Pharmaceuticals CPIX
2.51
35. Zynerba Pharmaceuticals ZYNE
2.47
36. Jupiter Wellness JUPW
2.39
37. Teva Pharmaceutical Industries TEVA
2.29
38. Theratechnologies THTX
2.24
39. Societal CDMO SCTL
2.21
40. Eagle Pharmaceuticals EGRX
2.19
41. Solid Biosciences SLDB
2.09
42. Avadel Pharmaceuticals AVDL
1.92
43. SCYNEXIS SCYX
1.92
44. Alpha Teknova TKNO
1.9
45. Clever Leaves Holdings CLVR
1.87
46. OptiNose OPTN
1.83
47. Ascend Wellness Holdings AAWH
1.77
48. Tilray Brands TLRY
1.75
49. Biofrontera BFRI
1.74
50. Flora Growth FLGC
1.63
51. Universe Pharmaceuticals UPC
1.61
52. Amphastar Pharmaceuticals AMPH
1.32
53. Amneal Pharmaceuticals AMRX
0.76
54. Harrow Health HROW
0.5

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.